The DOI matches its Crossref record; 129 of the 129 references it cites were found in a registry or an index.
Production platforms for biotherapeutic glycoproteins. Occurrence impact, and challenges of non-human sialylation
Open accessAbstract
One of the fastest growing fields in the pharmaceutical industry is the market for therapeutic glycoproteins. Today, these molecules play a major role in the treatment of various diseases, and include several protein classes, i.e., clotting factors, hormones, cytokines, antisera, enzymes, enzyme inhibitors, Ig-Fc-Fusion proteins, and monoclonal antibodies. Optimal glycosylation is critical for therapeutic glycoproteins, as glycans can influence their yield, immunogenicity and efficacy, which impact the costs and success of such treatments. While several mammalian cell expression systems currently used can produce therapeutic glycoproteins that are mostly decorated with human-like glycans, they can differ from human glycans by presenting two structures at the terminal and therefore most exposed position. First, natural human N-glycans are lacking the terminal Gal 1-3Gal (alpha-Gal) modification; and second, they do not contain the non-human sialic acid N-glycolylneuraminic acid (Neu5Gc). All humans spontaneously express antibodies against both of these glycan structures, risking increased immunogenicity of biotherapeutics carrying such non-human glycan epitopes. However, in striking contrast to the alpha-Gal epitope, exogenous Neu5Gc can be metabolically incorporated into human cells and presented on expressed glycoproteins in several possible epitopes. Recent work has demonstrated that this non-human sialic acid is found in widely varying amounts on biotherapeutic glycoproteins approved for treatment of various medical conditions. Neu5Gc on glycans of these medical agents likely originates from the production process involving the non-human mammalian cell lines and/or the addition of animal-derived tissue culture supplements. Further studies are needed to fully understand the impact of Neu5Gc in biotherapeutic agents. Similar concerns apply to human cells prepared for allo- or auto-transplantation, that have been grown in animal-derived tissue culture supplements.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, plants produce core α1,3-fructose and β1,2-xylose, which are completely absent in human cells and could be immunogenic (Karg et al., 2009;Ghaderi et al., 2012).”
From Therapeutic glycoprotein production in mammalian cells (2017) · cites this paper as Ghaderi et al., 2012
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wiederschain, G. Y. (2009) · Biochemistry (Moscow) · doi:10.1134/s0006297909090156 · Cited by 4,089
Siglecs and their roles in the immune system
Crocker, P. R., Paulson, J. C., & Varki, A. P. (2007) · Nature reviews. Immunology · doi:10.1038/nri2056 · Cited by 2,032
Self-citationCetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
Chung, C. H., Mirakhur, B., Chan, E., Le, Q.-T., Berlin, J., Morse, M., Murphy, B. A., Satinover, S. M., Hosen, J., Mauro, D., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa074943 · Cited by 1,521
The Impact of Glycosylation on the Biological Function and Structure of Human Immunoglobulins
Arnold, J. N., Wormald, M. R., Sim, R. B., Rudd, P. M., & Dwek, R. A. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141702 · Cited by 1,354
Chemical Diversity in the Sialic Acids and Related α-Keto Acids: An Evolutionary Perspective
Angata, T., & Varki, A. P. (2002) · Chemical Reviews · doi:10.1021/cr000407m · Cited by 1,254
Self-citationProduction of α1,3-Galactosyltransferase-Deficient Pigs
Phelps, C. J., Koike, C., Vaught, T. D., Boone, J. T., Wells, K. D., Chen, S.-H., Ball, S. F., Specht, S. M., Polejaeva, I. A., Monahan, J. A., et al. (2003) · Science · doi:10.1126/science.1078942 · Cited by 1,111
Baculovirus as versatile vectors for protein expression in insect and mammalian cells
Kost, T. A., Condreay, J. P., & Jarvis, D. L. (2005) · Nature Biotechnology · doi:10.1038/nbt1095 · Cited by 1,014
Human embryonic stem cells express an immunogenic nonhuman sialic acid
Martin, M. J., Muotri, A. R., Gage, F. H., & Varki, A. P. (2005) · Nature Medicine · doi:10.1038/nm1181 · Cited by 935
Self-citationJournal of the National Cancer Institute
(1993) · Journal of the American Dietetic Association · doi:10.1016/0002-8223(93)92324-q · Cited by 913
Wiseman, M. J. (2008) · Proceedings of The Nutrition Society · doi:10.1017/s002966510800712x · Cited by 902
Flagged first, then by citations
Research works printed but not linked: 7
- Borys MC, 2009, Biotechnol Bioeng
- Dahl SL, 2011, Sci Transl Med, 3
- Hanganutziu M, 1924, CR Séances Soc Biol, 91, 1457
- Higashi H, 1985, Cancer Research, 45, 3796
- Stanley P, 2009, Essentials of Glycobiology, 101
- Takiguchi M, 1984, Clin Exp Immunol, 56, 345
- Varki A, 2009, Essentials of Glycobiology, 281
Cited by
Sorted by citations
Human cell lines for biopharmaceutical manufacturing: history, status, and future perspectives
Dumont, J., Euwart, D., Mei, B., Estes, S., & Kshirsagar, R. (2016) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2015.1084266 · Cited by 483
Chemically modified and conjugated antimicrobial peptides against superbugs
Li, W., Separovic, F., O’brien-simpson, N. M., & Wade, J. D. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01026j · Cited by 443
Liu, L. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24444 · Cited by 428
Emerging principles for the therapeutic exploitation of glycosylation
Dalziel, M., Crispin, M., Scanlan, C. N., Zitzmann, N., & Dwek, R. A. (2014) · Science · doi:10.1126/science.1235681 · Cited by 447
The art of CHO cell engineering: A comprehensive retrospect and future perspectives
Fischer, S., Handrick, R., & Otte, K. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.10.015 · Cited by 336
Therapeutic glycoprotein production in mammalian cells
Lalonde, M.-E., & Durocher, Y. (2017) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2017.04.028 · Cited by 296
Advances in Mammalian cell line development technologies for recombinant protein production
Lai, T., Yang, Y., & Ng, S. (2013) · Pharmaceuticals · doi:10.3390/ph6050579 · Cited by 322
Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeutics
Räth, T., Baker, K., Dumont, J. A., Peters, R., Jiang, H., Qiao, S., Lencer, W. I., Pierce, G. F., & Blumberg, R. S. (2013) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2013.834293 · Cited by 289
Design and Production of Bispecific Antibodies
Wang, Q., Chen, Y., Park, J., Liu, X., Hu, Y., Wang, T., McFarland, K. S., & Betenbaugh, M. J. (2019) · Antibodies · doi:10.3390/antib8030043 · Cited by 295
Impact of host cell line choice on glycan profile
Goh, J. B., & Ng, S. K. (2017) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2017.1416577 · Cited by 243
Overview of the Purification of Recombinant Proteins
Wingfield, P. T. (2015) · Current Protocols in Protein Science · doi:10.1002/0471140864.ps0601s80 · Cited by 220
Therapeutic recombinant protein production in plants: Challenges and opportunities
Burnett, M., & Burnett, A. C. (2019) · Plants People Planet · doi:10.1002/ppp3.10073 · Cited by 222
Zhang, P., Woen, S., Wang, T., Liau, B., Zhao, S., Chen, C., Yang, Y., Song, Z., Wormald, M. R., Yu, C., et al. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.01.006 · Cited by 223
Glycan analysis of therapeutic glycoproteins
Zhang, L., Luo, S., & Zhang, B. (2016) · mAbs · doi:10.1080/19420862.2015.1117719 · Cited by 207
Involvement of a Non-Human Sialic Acid in Human Cancer
Samraj, A. N., Läubli, H., Varki, N., & Varki, A. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00033 · Cited by 196
Self-citationExploiting metabolic glycoengineering to advance healthcare
Agatemor, C., Buettner, M. J., Ariss, R., Muthiah, K., Saeui, C. T., & Yarema, K. J. (2019) · Nature Reviews Chemistry · doi:10.1038/s41570-019-0126-y · Cited by 189
The choice of mammalian cell host and possibilities for glycosylation engineering
Butler, M., & Spearman, M. (2014) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2014.06.010 · Cited by 175
In vitro and in vivo modifications of recombinant and human IgG antibodies
Liu, H., Ponniah, G., Zhang, H., Nowak, C., Neill, A., Gonzalez, N., Patel, R., Cheng, G. C., Kita, A., & Andrien, B. A. (2014) · mAbs · doi:10.4161/mabs.29883 · Cited by 174
Kolter, T. (2012) · ISRN Biochemistry · doi:10.5402/2012/506160 · Cited by 167
Rumachik, N. G., Malaker, S. A., Poweleit, N., Maynard, L. H., Adams, C. M., Leib, R. D., Cirolia, G., Thomas, D. R., Stamnes, S. J., Holt, K. H., et al. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.05.018 · Cited by 158
Therapeutic Fc‐fusion proteins: Current analytical strategies
Duivelshof, B. L., Murisier, A., Camperi, J., Fekete, S., Beck, A., Guillarme, D., & D’Atri, V. (2020) · Journal of Separation Science · doi:10.1002/jssc.202000765 · Cited by 153
Integrating plant molecular farming and materials research for next-generation vaccines
Chung, Y. H., Church, D. C., Koellhoffer, E. C., Osota, E. O., Shukla, S., Rybicki, E. P., Pokorski, J. K., & Steinmetz, N. F. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00399-5 · Cited by 149
Dhar, C., Sasmal, A., & Varki, A. P. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00807 · Cited by 127
Self-citationGlycans in immune recognition and response
Amon, R., Reuven, E. M., Ben‐Arye, S. L., & Padler‐Karavani, V. (2014) · Carbohydrate Research · doi:10.1016/j.carres.2014.02.004 · Cited by 115
Kaur, H. (2021) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2020.1869684 · Cited by 103
Engineering of Sialylated Mucin-type O-Glycosylation in Plants
Castilho, A., Neumann, L., Daskalova, S. M., Mason, H. S., Steinkellner, H., Altmann, F., & Strasser, R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.402685 · Cited by 96
Glycosylation control technologies for recombinant therapeutic proteins
Gupta, S. K., & Shukla, P. (2018) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-018-9430-6 · Cited by 99
Kastberg, L. L. B., Ard, R., Jensen, M. K., & Workman, C. T. (2022) · Frontiers in Fungal Biology · doi:10.3389/ffunb.2022.827704 · Cited by 92
The use of lectin microarray for assessing glycosylation of therapeutic proteins
Zhang, L., Luo, S., & Zhang, B. (2016) · mAbs · doi:10.1080/19420862.2016.1149662 · Cited by 90
Molecular farming on rescue of pharma industry for next generations
Moustafa, K., Makhzoum, A. B., & Trémouillaux‐Guiller, J. (2015) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2015.1049934 · Cited by 88
Using glyco-engineering to produce therapeutic proteins
Dicker, M., & Strasser, R. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1069271 · Cited by 73
Synthetic Glycobiology: Parts, Systems, and Applications
Kightlinger, W., Warfel, K. F., DeLisa, M. P., & Jewett, M. C. (2020) · ACS Synthetic Biology · doi:10.1021/acssynbio.0c00210 · Cited by 86
Padler‐Karavani, V. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.10.005 · Cited by 79
Biopharmaceutical Manufacturing: Historical Perspectives and Future Directions
Szkodny, A. C., & Lee, K. H. (2022) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-092220-125832 · Cited by 86
Ling, A. J. W., Chang, L. S., Babji, A. S., Latip, J., Koketsu, M., & Lim, S. J. (2021) · Food Chemistry · doi:10.1016/j.foodchem.2021.130755 · Cited by 78
Applications and analysis of hydrolysates in animal cell culture
Ho, Y. Y., Lu, H., Lim, Z. F. S., Lim, H. W., Ho, Y. S., & Ng, S. K. (2021) · Bioresources and Bioprocessing · doi:10.1186/s40643-021-00443-w · Cited by 82
Synthesis of N-Glycolylneuraminic Acid (Neu5Gc) and Its Glycosides
Kooner, A. S., Yu, H., & Chen, X. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02004 · Cited by 73
Glycosylated Biotherapeutics: Immunological Effects of N-Glycolylneuraminic Acid
Yehuda, S., & Padler-Karavani, V. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00021 · Cited by 71
Glycoengineering in CHO cells: advances in systems biology
Tejwani, V., Andersen, M. R., Nam, J. H., & Sharfstein, S. T. (2018) · Biotechnology Journal · doi:10.1002/biot.201700234 · Cited by 70
Cell-Free Synthesis Meets Antibody Production: A Review
Stech, M., & Kubick, S. (2015) · Antibodies · doi:10.3390/antib4010012 · Cited by 72
Röhrig, C. H., Choi, S. S. H., & Baldwin, N. J. (2015) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2015.1040113 · Cited by 72
Perspectives for Glyco-Engineering of Recombinant Biopharmaceuticals from Microalgae
Barolo, L., Abbriano, R. M., Commault, A. S., George, J., Kahlke, T., Fabris, M., Padula, M. P., Lopez, A., Ralph, P. J., & Pernice, M. (2020) · Cells · doi:10.3390/cells9030633 · Cited by 66
Vainauskas, S., Guntz, H., McLeod, E., McClung, C. M., Ruse, C. I., Shi, X., & Taron, C. H. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c04055 · Cited by 67
Improving Immunotherapy Through Glycodesign
Buettner, M. J., Shah, S. R., Saeui, C. T., Ariss, R., & Yarema, K. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02485 · Cited by 68
Strategies for Glycoengineering Therapeutic Proteins
Dammen‐Brower, K., Epler, P., Zhu, S. E., Bernstein, Z. J., Stabach, P. R., Braddock, D. T., Spangler, J. B., & Yarema, K. J. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2022.863118 · Cited by 70
The CAG promoter maintains high‐level transgene expression in HEK293 cells
Dou, Y.-Y., Lin, Y., Wang, T., Wang, X., Jia, Y., & Zhao, C. (2020) · FEBS Open Bio · doi:10.1002/2211-5463.13029 · Cited by 63
Therapeutic proteins: developments, progress, challenges, and future perspectives
Kumar, V., Barwal, A., Sharma, N., Mir, D. S., Kumar, P., & Kumar, V. (2024) · 3 Biotech · doi:10.1007/s13205-024-03958-z · Cited by 62
Therapeutic peptides: chemical strategies fortify peptides for enhanced disease treatment efficacy
Li, Q., Chao, W., & Qiu, L. (2025) · Amino Acids · doi:10.1007/s00726-025-03454-5 · Cited by 64
Serum-Free Medium for Recombinant Protein Expression in Chinese Hamster Ovary Cells
Li, W., Fan, Z., Lin, Y., & Wang, T. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.646363 · Cited by 58
Khan, T., Islam, R., Jerin, T. J., Mahmud, A., Khatun, S., Kobir, A., Islam, M. N., Akter, A., & Mondal, S. I. (2021) · PLoS ONE · doi:10.1371/journal.pone.0253393 · Cited by 57
N-Glycosylation of Extracellular Vesicles from HEK-293 and Glioma Cell Lines
Costa, J., Gatermann, M., Nimtz, M., Kandzia, S., Glatzel, M., & Conradt, H. S. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.7b05455 · Cited by 56
Cuccui, J., & Wren, B. W. (2014) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12321 · Cited by 55
Product Quality Considerations for Mammalian Cell Culture Process Development and Manufacturing
Gramer, M. J. (2013) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2013_214 · Cited by 53
The present state of the art in expression, production and characterization of monoclonal antibodies
Gaughan, C. L. (2015) · Molecular Diversity · doi:10.1007/s11030-015-9625-z · Cited by 57
Song, T., Özcan, S., Becker, A., & Lebrilla, C. B. (2014) · Analytical Chemistry · doi:10.1021/ac501102t · Cited by 52
Human cell lines for the production of recombinant proteins: on the horizon
Fliedl, L., Grillari, J., & Grillari‐Voglauer, R. (2014) · New Biotechnology · doi:10.1016/j.nbt.2014.11.005 · Cited by 53
Manufacturing process used to produce long-acting recombinant factor VIII Fc fusion protein
McCue, J. T., Kshirsagar, R., Selvitelli, K., Lü, Q., Zhang, M., Mei, B., Peters, R., Pierce, G. F., Dumont, J., Raso, S. W., et al. (2015) · Biologicals · doi:10.1016/j.biologicals.2015.05.012 · Cited by 48
Self-citationLuo, S., & Zhang, B. (2023) · Pharmaceutical Research · doi:10.1007/s11095-023-03628-4 · Cited by 46
Characterization of anti-CD20 monoclonal antibody produced by transgenic silkworms (Bombyx mori)
Tada, M., Tatematsu, K., Ishii‐Watabe, A., Harazono, A., Takakura, D., Hashii, N., Sezutsu, H., & Kawasaki, N. (2015) · mAbs · doi:10.1080/19420862.2015.1078054 · Cited by 46
Blondeel, E. J. M., & Aucoin, M. G. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.06.008 · Cited by 46
Evolution of sialic acids: Implications in xenotransplant biology
Paul, A., & Padler‐Karavani, V. (2018) · Xenotransplantation · doi:10.1111/xen.12424 · Cited by 46
Zhao, C., Guo, X. H., Chen, S.-J., Li, C., Yang, Y., Zhang, J., Chen, S.-N., Jia, Y., & Wang, T. (2017) · Scientific Reports · doi:10.1038/srep42805 · Cited by 44
Varki, A. P. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.07.011 · Cited by 44
Self-citationFermentanomics informed amino acid supplementation of an antibody producing mammalian cell culture
Read, E. K., Bradley, S. A., Smitka, T. A., Agarabi, C. D., Lute, S. C., & Brorson, K. (2013) · Biotechnology Progress · doi:10.1002/btpr.1728 · Cited by 42
Lin, P.-C., Chan, K. F., Kieß, I. A., Tan, J. L., Shahreel, W., Wong, S.-Y., & Song, Z. (2019) · mAbs · doi:10.1080/19420862.2019.1612690 · Cited by 42
Glycosylation of Therapeutic Proteins: A Critical Quality Attribute
Delobel, A. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1241-5_1 · Cited by 42
Patrucco, L., Chiesa, A. D., Soluri, M. F., Fasolo, F., Takahashi, H., Carninci, P., Zucchelli, S., Santoro, C., Gustincich, S., Sblattero, D., et al. (2015) · Gene · doi:10.1016/j.gene.2015.05.070 · Cited by 42
Generation of cattle knockout for galactose‐α1,3‐galactose and N‐glycolylneuraminic acid antigens
Perota, A., Lagutina, I., Duchi, R., Zanfrini, E., Lazzari, G., Judor, J., Conchon, S., Bach, J., Bottio, T., Gerosa, G., et al. (2019) · Xenotransplantation · doi:10.1111/xen.12524 · Cited by 41
Oldenburg, J., Lacroix‐Desmazes, S., & Lillicrap, D. (2015) · Haematologica · doi:10.3324/haematol.2014.112821 · Cited by 40
Glycoengineering of CHO Cells to Improve Product Quality
Wang, Q., Yin, B., Chung, C., & Betenbaugh, M. J. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6972-2_2 · Cited by 42
An Effective Bacterial Fucosidase for Glycoprotein Remodeling
Tsai, T.-I., Li, S., Liu, C.-P., Chen, K. Y., Shivatare, S. S., Lin, C., Liao, S.-F., Lin, C.-W., Hsu, T.-L., Wu, Y., et al. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00821 · Cited by 38
Production of recombinant coagulation factors: Are humans the best host cells?
Swiech, K., Picanço‐Castro, V., & Covas, D. T. (2017) · Bioengineered · doi:10.1080/21655979.2017.1279767 · Cited by 38
Glycoengineering Chinese hamster ovary cells: a short history
Donini, R., Haslam, S. M., & Kontoravdi, C. (2021) · Biochemical Society Transactions · doi:10.1042/bst20200840 · Cited by 37
Ni, W., Bones, J., & Karger, B. L. (2013) · Analytical Chemistry · doi:10.1021/ac3031898 · Cited by 36
Shapiro, A. D. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.819339 · Cited by 37
Müller-Kräuter, H., Fehling, S. K., Dorna, J., Urbanowicz, R. A., Oestereich, L., Krebs, Y., Kolesnikova, L., Schauflinger, M., Krähling, V., Magassouba, N., et al. (2020) · npj Vaccines · doi:10.1038/s41541-020-00219-x · Cited by 36
Furukawa, J., Tsuda, M., Okada, K., Kimura, T., Piao, J., Tanaka, S., & Shinohara, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128300 · Cited by 36
Liu, J., Wang, J., Li, F., Chen, X., Hu, D., Deng, X., Poon, H. F., Wang, H., Liu, X., & Tan, W. (2015) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-015-1864-8 · Cited by 36
Radoman, B., Grünwald‐Gruber, C., Schmelzer, B., Zavec, D., Gasser, B., Altmann, F., & Mattanovich, D. (2020) · Biotechnology Journal · doi:10.1002/biot.202000266 · Cited by 35
Fernández‐Tejada, A., Vadola, P. A., & Danishefsky, S. J. (2014) · Journal of the American Chemical Society · doi:10.1021/ja503545r · Cited by 35
Dong, Q., Yan, X., Liang, Y., & Stein, S. E. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b01046 · Cited by 34
Cell Surface and Membrane Engineering: Emerging Technologies and Applications
Saeui, C. T., Mathew, M. P., Liu, L., Urias, E., & Yarema, K. J. (2015) · Journal of Functional Biomaterials · doi:10.3390/jfb6020454 · Cited by 32
Synthesis of the Antimicrobial S‐Linked Glycopeptide, Glycocin F
Brimble, M. A., Edwards, P. J. B., Harris, P. W. R., Norris, G. E., Patchett, M. L., Wright, T. H., Yang, S., & Carley, S. E. (2015) · Chemistry - A European Journal · doi:10.1002/chem.201405692 · Cited by 33
Stutz, H. (2022) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2022.115089 · Cited by 36
Improving recombinant protein production in CHO cells using the CRISPR-Cas system
Kalkan, A. K., Palaz, F., Semeniuk, S., Elmousa, N., Ledezma, Y., Cachat, É., & Rios‐Solis, L. (2023) · Biotechnology Advances · doi:10.1016/j.biotechadv.2023.108115 · Cited by 33
McCue, J. T., Osborne, D., Dumont, J., Peters, R., Mei, B., Pierce, G. F., Kobayashi, K., & Euwart, D. (2014) · Haemophilia · doi:10.1111/hae.12451 · Cited by 33
Orthogonal Technologies for NISTmAb N-Glycan Structure Elucidation and Quantitation
Prien, J. M., Stöckmann, H., Albrecht, S., Millán‐Martín, S., Varatta, M., Furtado, M., Hosselet, S., Wang, M., Formolo, T., Rudd, P. M., et al. (2015) · ACS symposium series · doi:10.1021/bk-2015-1201.ch004 · Cited by 32
Study of structure‐dependent chromatographic behavior of glycopeptides using reversed phase nanoLC
Kozlík, P., Goldman, R., & Šanda, M. (2017) · Electrophoresis · doi:10.1002/elps.201600547 · Cited by 32
Glycoengineering of Mammalian Expression Systems on a Cellular Level
Heffner, K. M., Wang, Q., Hızal, D. B., Can, Ö., & Betenbaugh, M. J. (2018) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2017_57 · Cited by 35
Binz, R. L., Tian, E., Sadhukhan, R., Zhou, D., Hauer‐Jensen, M., & Pathak, R. (2019) · Scientific Reports · doi:10.1038/s41598-019-47002-0 · Cited by 32
Gibbons, L. A., Rafferty, C., Robinson, K., Abad, M. C., Maslanka, F., Le, N., Mo, J., Clark, K., Madden, F., Hayes, R., et al. (2021) · Biotechnology Progress · doi:10.1002/btpr.3223 · Cited by 32
Sialic acids in infection and their potential use in detection and protection against pathogens
Dedola, S., Ahmadipour, S., de Andrade, P., Baker, A. N., Boshra, A. N., Chessa, S., Gibson, M. I., Hernando, P. J., Ivanova, I. M., Lloyd, J., et al. (2023) · RSC Chemical Biology · doi:10.1039/d3cb00155e · Cited by 31
Wei, M., Mi, C., Jing, C., & Wang, T. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.879222 · Cited by 34
Compte, M., Álvarez‐Cienfuegos, A., Nuñez‐Prado, N., Sainz-Pastor, N., Blanco‐Toribio, A., Pescador, N., Sanz, L., & Álvarez‐Vallina, L. (2014) · OncoImmunology · doi:10.4161/onci.28810 · Cited by 31
Blondeel, E. J. M., Braasch, K., McGill, T., Chang, D., Engel, C., Spearman, M. A., Butler, M., & Aucoin, M. G. (2015) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2015.09.014 · Cited by 29
Serum-free suspension culturing of human cells: adaptation, growth, and cryopreservation
Biaggio, R. T., Abreu-Neto, M. S., Covas, D. T., & Swiech, K. (2015) · Bioprocess and Biosystems Engineering · doi:10.1007/s00449-015-1392-9 · Cited by 30
Engineering of human-type O-glycosylation inNicotiana benthamianaplants
Strasser, R. (2012) · Bioengineered · doi:10.4161/bioe.22857 · Cited by 29
Бекхановна, Б. З., Анатольевна, В. Л., Fetisova, Y., Александровна, М. Н., Ovchinnikova, M. M., Tischenko, M., Scherbatyuk, Y., Kolotovkina, A., Miskun, A. A., Kasyanova, G. V., et al. (2019) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2019.07.032 · Cited by 29
Koenitzer, J. D., Müller, M. M., Leparc, G., Pauers, M., Bechmann, J., Schulz, P., Schaub, J., Enenkel, B., Hildebrandt, T., Hampel, M., et al. (2015) · Biotechnology Journal · doi:10.1002/biot.201400652 · Cited by 28
Stable Protein Sialylation in Physcomitrella
Bohlender, L. L., Parsons, J., Hoernstein, S. N. W., Rempfer, C., Ruiz-Molina, N., Lorenz, T., Rodríguez-Jahnke, F., Figl, R., Fode, B., Altmann, F., et al. (2020) · Frontiers in Plant Science · doi:10.3389/fpls.2020.610032 · Cited by 29
Metadata
- Authors
- Ghaderi, D., Zhang, M., Hurtado-Ziola, N., & Varki, A.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Varki, Ajit
- Venue
- Biotechnology and Genetic Engineering Reviews
- Publisher
- Informa UK Limited
- Published
- 2012-01
- Volume
- 28
- Issue
- 1
- Pages
- 147-176
- ISSN
- 0264-8725 (ISSN-L)
- 2046-5556
- OpenAlex
- W1997984454
- Cited by
- 320
- References
- 128
- Citations by year
- 2026: 9 · 2025: 11 · 2024: 15 · 2023: 13 · 2022: 22 · 2021: 29 · 2020: 29 · 2019: 30 · 2018: 25 · 2017: 30 · 2016: 24 · 2015: 36 · 2014: 23 · 2013: 21 · 2012: 3
- FWCI
- 10.68
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Biotechnology and Genetic Engineering Reviews (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Transgenic Plants and Applications
- Keywords
- N-glycolylneuraminic acid, alpha-gal epitope, therapeutic glycoproteins, biologic therapy, N-glycosylation, immunogenicity, sialic acid, monoclonal antibodies
- MeSH terms
- Animals, Antibodies, Monoclonal, Epitopes, Biotechnology, Carbohydrate Sequence, Cattle, Cells, Cultured, Culture Media, Disaccharides, Glycoproteins, Glycosylation, Cricetinae, Humans, Insecta, Rabbits, Recombinant Proteins, Sialic Acids, Swine, Cell Culture Techniques, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
